1. home
  2. #tags
  3. Feasibility

Discover Latest #Feasibility News, Articles and Videos with Contenting

The Feasibility News section is designed to provide quick access to the latest news and articles related to feasibility studies. The content is provided by Google News.

HepaRegeniX Doses First Patient in Phase Ib Trial with Small Molecule Inhibitor HRX-215 to Promote Liver Regeneration - ForexTV

Tuebingen, Germany, June 10, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver disease, today announced that the first patient has been dosed in their Phase Ib clinical trial of its lead candidate HRX-215. The trial is evaluating the safety and efficacy of HRX-215, an orally available small-molecule inhibitor of MKK4, in patients undergoing partial liver resection due to liver metastases deriving from colorectal cancer. HXR-215 is designed to treat advanced-stage liver disease by increasing the regenerative capacity of hepatocytes. An initial data readout is planned for the second half of 2025. “We aim to address a critical unmet need in patients with advanced liver disease who are often considered inoperable due to the limited regenerative capacity of the remaining liver after partial resection,” said Linda Greenbaum, Chief Medical Officer at HepaRegeniX. “HRX-215 may offer a new therapeutic option by promoting hepatocyte regeneration, thereby increasing the safety and feasibility of liver resections in patients who have insufficient predicted postoperative liver mass and/or reduced liver function associated with fatty liver (steatosis) or liver scarring (fibrosis).” “Dosing the first patient in this trial marks an important milestone for HepaRegeniX as we advance HRX-215 into the next stage of clinical development,” said Elias Papatheodorou, Chief Executive Officer at HepaRegeniX. “Together with our recently completed €21.5 million Series C financing round, we are well-positioned to advance HRX-215 through clinical development and ultimately improve outcomes for patients facing limited treatment options.” The randomized, double-blinded Phase Ib/IIa trial (NCT06638502), conducted in the United States, will evaluate the safety and efficacy of HRX-215 in 85 patients with liver metastases originating from colorectal cancer. Participants will be divided into three cohorts: (1) active treatment arm for patients requiring minor liver resection ( 30%), (2) active treatment arm including patients requiring major liver resection (50 – 72%), and (3) active treatment and a placebo comparator arms for patients requiring major liver resection. The study builds on preclinical and clinical data published in Cell in March 2024, which demonstrated the potential of HRX-215 to significantly boost liver regeneration and prevent post-hepatectomy liver failure (PHLF) in animal models and which demonstrated acceptable safety profile and pharmacokinetics in a Phase I trial in healthy participants. The compound showed favorable safety and tolerability, with no drug-related adverse events observed. About HRX-215 and Liver RegenerationPatients with late-stage liver disease often have limited therapeutic options beyond surgical intervention. Successful liver resection depends on the ability of the remaining liver, known as the future liver remnant (FLR), to sustain essential functions and regenerate. When the FLR is insufficient in volume or function, the risk of post-operative liver failure increases significantly, rendering many patients ineligible for potentially curative surgery. HRX-215 is an orally available small molecule inhibitor of mitogen-activated protein kinase kinase 4 (MKK4), a key regulator of liver regeneration. By selectively inhibiting MKK4, HRX-215 has been shown in preclinical models to stabilize and protect hepatocytes, while accelerating and enhancing regenerative processes, even in compromised or diseased livers. This therapeutic approach has the potential to expand surgical eligibility to patients requiring extended liver resection who would otherwise be deemed inoperable, offering a new path to potentially lifesaving treatment. About HepaRegeniX GmbHHepaRegeniX is advancing therapies to treat acute and chronic liver diseases based on the groundbreaking discoveries of a novel cellular target and small molecules that enable the liver to regenerate rapidly. We do so by harnessing the liver’s inherent regenerative power not only in healthy but also in diseased livers. The company’s lead candidate, HRX-215, an orally available small molecule currently in a Phase Ib/IIa trial, selectively inhibits Mitogen-Activated Protein (MAP) Kinase Kinase 4 (MKK4), a master regulator of liver regeneration. Building on demonstrated safety in clinical trials, HepaRegeniX is progressing HRX-215 to prevent post-hepatectomy liver failure, facilitate transplantation of smaller living donor liver grafts, and treat severe alcohol-associated hepatitis. Beyond liver diseases, the company is also developing HRX-233 to target kinase inhibitor treatment resistance in KRAS-driven tumors. HepaRegeniX is backed by experienced life science investors, including Vesalius Biocapital IV, Novo Holdings A/S, Boehringer Ingelheim Venture Fund (BIVF), Coparion, High-Tech Gründerfonds, Ascenion GmbH and Wellington Partners. Visit our website at www.heparegenix.com to learn more about the company. For further information, please contact:HepaRegeniX GmbHElias PapatheodorouChief Executive Officerinfo@heparegenix.com Media InquiriesTrophic CommunicationsCharlotte Spitz or Gretchen Schweitzer Tel: +49 171 351 2733Email: heparegenix@trophic.eu

LEADING EDGE MATERIALS' INVESTOR UPDATE AND SIGNIFICANT ACTIVITIES - ForexTV

LEADING EDGE MATERIALS’ INVESTOR UPDATE ON SIGNIFICANT ACTIVITIES Vancouver, June 22, 2025 – Leading Edge Materials Corp. (“Leading Edge Materials” or the “Company”) (TSXV: LEM) (Nasdaq First North: LEMSE) (OTCQB: LEMIF) provides an investor update on significant activities. Overview - Becoming a European CRM producer Concerns about critical raw materials - security of supply, supply chain resilience and defence requirements - have been recurring themes at conferences attended by the Company in recent months, with Heavy Rare Earth Elements (“HREEs”) and natural graphite frequently mentioned; geopolitical uncertainty is the new norm and it is driving partnership, collaboration and greater levels of support for mining. On June 17, 2025, the G7 Critical Minerals Action Plan was announced focused on ‘diversifying the responsible production and supply of critical minerals, encouraging investments in critical mineral projects and local value creation, and promoting innovation’ in the G7, and with partners beyond, working together and ‘to swiftly protect our economic and national security’'. At the EIT Raw Materials Summit in March, graphite and defence were frequent mentions on the first day, with widespread calls for more action, now the Critical Raw Materials Act is in force, and the need for more money. Against this backdrop, LEM’s Critical Raw Materials (“CRMs”) portfolio is very well positioned and the Company is working on becoming a European CRM producer. Norra Kärr is a globally significant source of HREEs with the economic advantage of valuable industrial minerals, specifically nepheline syenite; a production start within 3–4 years is in reach. In parallel, we are evaluating the restart of production from the fully built and permitted Woxna Graphite mine. On exploration, and possibly future production, we have strengthened our position in Romania, with Leading Edge Materials Romania (“LEMR”) being granted ownership and operational permits for the Avram Iancu mine by CNCAN (National Commission for Control of Nuclear Activities) under the supervision of IAEA (International Atomic Energy Agency) and European Atomic Energy Community (EURATOM). This is significant recognition of the funds invested and commitment made by the Company in country and gives us real ‘owner-operator’ autonomy over a deposit described as ‘one of the most important deposits [historically] in operation in Bihor (IAEA report, November 1997) and noted for uranium, copper, lead, nickel and zinc mineralization (IMWA Symposium 2007: Water in Mining Environments, May 2007). Norra Kärr – Application progresses On 8 April, the CEO was invited to Solvay’s inauguration of a new production line for rare earth permanent magnets (“REPM”) in France. Solvay is partnering with emerging mining and recycling players to accelerate the establishment of a robust, reliable, and sustainable supply chain, crucial for Europe’s competitiveness and industrial and technological sovereignty. The essential creation of a European rare earth supply chain was again the theme of Solvay’s presentation at The Rare Earth Industry Association (“REIA”) Conference in Montreal last week. In recent months, the Company’s application for a new Exploitation Concession (“Bearbetningskoncession”), 25-year mining lease has been out for consultation. The County Administrative Boards (CABs) of Jönköping and Östergötland have now communicated that they, at this time, cannot approve the Environmental Impact Assessment (“EIA”) submitted by the Company’s Swedish subsidiary GREENNA Mineral AB. The CABs state that additional data and analysis are needed. The decision and statement from the CABs tell us that we have some additional work to do describing the impact of the project, with an emphasis on water, cultural values and impact on other forms of land use. Obviously, these are crucial topics that must be addressed properly in our application. It should be noted that while the CABs reject our application as it currently stands, they also offer us the opportunity to supplement it.   The Company’s Swedish environmental permitting team is already reviewing the comments from the CABs in detail, and we believe that we will be able to respond with supplementary information to our application to the satisfaction of the CABs and other stakeholders. Developing Norra Kärr is of the utmost importance not only for Sweden, but for Europe. Geopolitical tensions and unstable global trade flows mean that it is more important than ever to produce HREEs in Sweden. That will enable us to extract metals that are essential to both achieving a complete energy transition and secure our defences. Europe relies heavily on China for its imports of HREEs. China dominates all stages of the rare earth elements supply chain from mining to permanent magnet manufacturing. The speed at which China can build new production is awe inspiring, and, with an established industrial base decades in the making, it has the ability to innovate beyond anything Europe can dream. Europe is compelled to change its ways, think and act radically differently to have a secure future. Highlighting Sweden’s role in CRMs, Sweden’s Energy, Business and Industry Minister Ebba Busch recently stated that “Sweden has unique opportunities to be and remain a strong player in global mineral politics. We have the most sustainable mining industry in the world – ethically sustainable, environmentally sustainable, and with good working conditions.” The Company is developing and will manage Norra Kärr with social acceptance and transparency towards the local community as its primary considerations. The new application for mining license represents a reduction of 65 percent in land area compared to the old application which was initially approved in 2013. Chemical processing of the HREE-rich eudialyte concentrate will take place at an existing industrial location, and not on site. With the elimination of chemical processing, the Company has largely addressed stakeholder concerns about pollution risk to Lake Vättern. The changes to the application are in response to the public’s concerns to the old application. This is what responsible mining companies do, they listen. Proposed activities at site are now similar to those of a quarrying operation; similar to what already exists around Lake Vättern. Our target is to make products from 100% of what we extract, HREE-rich eudialyte concentrate and industrial mineral nepheline syenite being the two most critically important. Looking ahead, a Swedish mining license (sw. Bearbetningskoncession) is decided by the Chief Mining Inspector. If the Chief Mining Inspector and CABs disagree about an application, the Government can then make the decision. Our objective is to provide supplementary information and explanation on the sufficiency of our enhanced application to the full satisfaction of the CABs, so that the development of Norra Kärr can progress unimpeded. Alongside the mining lease process, Pre-feasibility (“PFS”) workstreams are underway. Testwork has now been completed on nepheline syenite and aegirine to determine their mineralogy, chemical composition, and leachate chemistry. The promising results are being used to determine possible market segments and specifications that can be achieved, potential demand and pricing, to be included in an updated PFS economic model for Norra Kärr. The Company envisages the PFS will be completed in Q1 2026. Woxna Graphite Mine – Potential Restart The Company is collaborating with an engineering consultant on updating the in-house production restart study, originally completed in 2022. We have initiated crushing testwork on Woxna ore to explore improved liberation and preservation of graphite flakes. Additionally, metallurgical testwork is planned to evaluate potential upgrades to the processing plant, aimed at optimizing performance. Our objective is to produce a high-quality, high-grade flake graphite concentrate. We continue to receive inbound enquiries and remain optimistic about Woxna’s future prospects. This ongoing workstream will support the development of a new business plan, which could facilitate future project financing discussions and potentially unlock access to Swedish or EU public funding. Bihor Sud – Major Milestone Exploration activities at the Bihor Sud project have continued steadily, bolstered by the addition of four new geologists who joined the team in January. Recent work has included underground mapping, diamond drilling, geophysical surveys, core logging, and sampling. To accelerate progress, the Company plans to change drilling contractors within the next one to two months. The Company remains focused on defining a large-scale, mineable mineral resource at Bihor Sud, particularly within gallery G2, where exploration is targeting promising zinc-lead-copper-silver mineralization. Results to date have been encouraging and highlight the project's strong potential for a significant polymetallic discovery. A major milestone was the granting of ownership and operational permits for the Avram Iancu mine. Historical mining and exploration at this site have left behind hundreds of kilometres of galleries and underground workings. In addition to ongoing work at G2, the Romanian team has initiated preliminary investigations at Avram Iancu. They successfully located the entrance to a 3-kilometre tunnel observed to be in good condition. Based on historical reports, this tunnel connects with up to 15 kilometres of workings and zones containing massive sulphides in carbonate-replacement deposits with primary copper-bearing minerals—including chalcocite and bornite. On behalf of the Board of Directors,Leading Edge Materials Corp. Kurt Budge, CEO For further information, please contact the Company at:info@leadingedgematerials.comwww.leadingedgematerials.com About Leading Edge Materials Leading Edge Materials is a Canadian public company focused on developing a portfolio of critical raw material projects located in the European Union. Critical raw materials are determined as such by the European Union based on their economic importance and supply risk. They are directly linked to high growth technologies such as lithium-ion batteries and permanent magnets for electric motors, wind turbines and defense applications. The portfolio of projects includes the 100% owned Woxna Graphite mine (Sweden), 100% owned Norra Kärr Heavy Rare Earth Elements project (Sweden), and the 51% owned Bihor Sud Nickel Cobalt exploration alliance (Romania). Additional Information The information was submitted for publication through the agency of the contact person set out above, on June 22, 2025, at 23:30 Vancouver time. Leading Edge Materials is listed on the TSXV under the symbol “LEM”, OTCQB under the symbol “LEMIF” and Nasdaq First North Stockholm under the symbol “LEMSE”. Svensk Kapitalmarknadsgranskning (“SKMG”) is the Company’s Certified Adviser for the Nasdaq First North Growth Market (Stockholm) and may be contacted via email ca@skmg.se or by phone +46 (0)8 913 008. Reader Advisory This news release may contain statements which constitute “forward-looking information”, including statements regarding the plans, intentions, beliefs and current expectations of the Company, its directors, or its officers with respect to the future business activities of the Company. The words “may”, “would”, “could”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions, as they relate to the Company, or its management, are intended to identify such forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future business activities and involve risks and uncertainties, and that the Company’s future business activities may differ materially from those in the forward-looking statements as a result of various factors, including, but not limited to, fluctuations in market prices, changes in the Company’s intended use of proceeds from the Private Placement, successes of the operations of the Company, continued availability of capital and financing and general economic, market or business conditions. There can be no assurances that such information will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. The Company does not assume any obligation to update any forward-looking information except as required under the applicable securities laws. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this news release. Attachment 20250621 LEM - Update on Significant Activities FINAL

Caledonia Mining Corporation Plc: Results for the Quarter ended June 30, 2025 - ForexTV

Details of Management Conference Call Strong Performance Driven by Record Q2 Production and Higher Gold Prices ST HELIER, Jersey, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (“Caledonia” or “the Company”) (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) announces its operating and financial results for the quarter ended June 30, 2025 (“Q2 2025” or the “Quarter”). Further information on the financial and operating results for the Quarter can be found in the Management Discussion and Analysis (“MD&A”) and the unaudited condensed consolidated interim financial statements, which are available on the Company’s website and are being filed on SEDAR+. Q2 2025 HIGHLIGHTS Financial Highlights: Gold revenue of $65.0 million (second quarter of 2024 (“Q2 2024”): $50.1 million, +30%)Gross profit of $33.8 million (Q2 2024: $22.9 million, +48%)EBITDA of $39.5 million (including one off profit on sale of solar plant in April 2025 of $8.5m) (Q2 2024: $20.4 million, +94%)Net profit attributable to shareholders of the Company of $20.5 million (Q2 2024: $8.3 million, +147%)Adjusted EPS of 113.9 cents (Q2 2024: 44.6 cents, +155%)Net cash from operating activities of $28.1 million (Q2 2024: $19.1 million, +47%)Net cash position (including fixed term deposits) improved to $26.2 million (Q2 2024: negative $1.4 million)A dividend of 14 cents per share was declared today, August 11, 2025Completion of the solar plant sale (through the sale of the Zimbabwe subsidiary owning the plant) to CrossBoundary Energy Holdings for $22.35 million which was paid in cash Operational Highlights: Production at Blanket Mine of 21,070 ounces (Q2 2024: 20,773 ounces, +1.4%)Production guidance at Blanket Mine for 2025 increased to 75,500 - 79,500 ounces of goldOn-mine cost per ounce of $1,123 (Q2 2024: $1,013, +10.9%)All-in sustaining cost (“AISC”) per ounce of $1,805 (Q2 2024: $1,485, +21.5%)Average realised gold price of $3,188 per ounce (Q2 2024: $2,302, +38.5%)Continued progress on Bilboes feasibility study and Motapa exploration programmeContinued exploration at Blanket to upgrade inferred resources and explore new areas within the mining lease area. Mark Learmonth, Chief Executive Officer, commented: “Caledonia has delivered another strong quarter, highlighted by record second-quarter gold production at Blanket and a substantial increase in profitability, reflecting strong operational performance and a higher gold price environment. I would like to thank the team for their hard work and contribution. “The successful sale of our solar plant in April has strengthened our balance sheet and ensures a reliable, long-term renewable energy supply for Blanket Mine. “Our ongoing drilling campaign at Blanket Mine continues to demonstrate encouraging results, further improving our confidence in the mineral resource and pointing to additional future mineral resource growth. The grades and widths we are seeing from this drilling campaign are as good as and, in some cases, considerably better than results from previous drilling campaigns. “We are encouraged by the progress on the Bilboes feasibility study, and we continue to evaluate opportunities that could materially improve project economics. At the same time, our exploration programme at Motapa is advancing well, with a clear focus on identifying both sulphide and oxide resources that could support near-term production and longer-term growth. “Looking ahead, we remain focused on delivering our increased production guidance at Blanket, and advancing our growth pipeline in a way that maximises long-term value for shareholders. With a strong operational base and a clear strategic roadmap, Caledonia is well positioned to continue building on this positive momentum.” Revenue and Profit Revenue for the Quarter was $65.0 million, a 30% increase from $50.1 million in Q2 2024. This improvement was driven by higher gold prices and slightly higher production. Gross profit increased to $33.8 million (Q2 2024: $22.9 million). Net profit attributable to shareholders of the Company more than doubled to $20.5 million (Q2 2024: $8.3 million), while adjusted EPS rose to 113.9 cents from 44.6 cents in Q2 2024. Costs Consolidated on-mine cost per ounce increased by 10.9% to $1,123 (Q2 2024: $1,013), primarily due to higher labour and consumables costs at Blanket Mine. Labour costs increased due to a higher headcount, inflationary salary increases, bonuses paid for higher production, and overtime worked. Consumable costs per ounce at Blanket increased due to higher repair and maintenance activities at the metallurgical plant and on underground trackless mining machinery in the Quarter. Consolidated AISC rose to $1,805 per ounce (Q2 2024: $1,485); this was as expected due to higher on-mine costs and increased sustaining capital expenditure (as planned). Full year sustaining capital expenditure remains on target. Cash Generation During the half year ended 30 June 2025, Caledonia generated operating cash inflows of $41.3 million (Q2 2025: $28.1 million), driven by higher production at Blanket and a favourable gold price environment. An additional $22.35 million (pre-tax) was received in the Quarter from the sale of the solar plant, further strengthening the group’s cash position. This strong cash generation supported continued investment in strategic growth. The group invested $17.7 million during the half year (Q2 2025: $10.5 million) in property, plant, and equipment on key infrastructure at Blanket. A further $3.1 million during the half year (Q2 2025: $1.8 million) was allocated to exploration and evaluation activities, primarily at Bilboes and Motapa. To optimise short-term returns and strengthen the balance sheet, $18.0 million was placed into fixed-term deposits during the Quarter. Financing activities had a net outflow of $6.0 million during the half year (Q2 2025: $6.9 million), with three key drivers being net proceeds from loans and bond issuance for supporting capital projects making a positive contribution of $3.2 million (Q2 2025: $0.8 million) and an outflow of $9.0 million (Q2 2025: $7.6 million) returned to Caledonia and Blanket minority shareholders through dividends. Additionally, $0.1 million (Q2 2025: $0.1 million) paid lease liabilities in the period. As a result of all the key movements above, cash and cash equivalents increased by $16.9 million during the half year (Q2 2025: $12.8 million) to $8.2 million. This reflects Caledonia’s prudent treasury management and balanced approach to deploying capital for both growth and shareholder returns. OPERATIONAL REVIEW Blanket Mine Blanket Mine produced 21,070 ounces of gold in Q2 2025, a 1.4% increase from 20,773 ounces in Q2 2024. The increase was due to higher grades and better plant recoveries. As announced on July 16, 2025, Blanket's annual production guidance for 2025 was increased to 75,500 - 79,500 ounces, reflecting a strong operational performance. The plant recovery rate in the Quarter was 94.4%, which represents a new record. The improved recovery was due to the introduction of an additional tank in the carbon-in-leach circuit, closer attention to dosage levels of reagents and improved process controls. The improved recovery rate in the Quarter compared to the average recovery of 93.6% in 2024 resulted in approximately 175 ounces of additional gold production in the Quarter. In the absence of unforeseen changes to the ore feed grade or mineralogy, it is anticipated that the recovery rate achieved in the Quarter can be sustained. The metallurgical team at Blanket continues to evaluate opportunities to achieve further improvements in recovery. Exploration at Blanket is ongoing with encouraging high grade results. The programme is aimed at evaluating the continuity of the mineralised zones on the Blanket, Eroica and Lima orebodies (which comprise three of the main orebodies at Blanket Mine). The objectives of the programme are to increase the confidence levels of the existing mineral resource and to grow the mineral resource estimate below the 34 level (1,110 metres) of the mine.  Results from 6,976 metres of underground drilling from January 2024 to the end of April 2025 indicate that the existing Blanket and Eroica orebodies have grades and widths which are generally better than expected, while the Lima orebody is shown to continue below 22 level (750 metres). A new potential orebody has been intersected in the Blanket orebody area of the mine, with impressive grades and widths. Solar Plant Sale Summary On 11 April, 2025, Caledonia sold its Zimbabwe subsidiary, Caledonia Mining Services (Private) Limited (“CMS”), to CrossBoundary Energy Holdings for $22.35 million in cash. CMS owns the 12.2MWac solar plant powering Blanket Mine, which will continue supplying energy under an exclusive agreement. Bilboes Project The feasibility study for the Bilboes sulphide project is progressing well and we continue to evaluate new opportunities which may enhance the economics of the project and the potential for near-term, low capital revenue opportunities elsewhere in Caledonia's asset portfolio to contribute to funding the Bilboes project. In the Quarter, 372 ounces of gold were produced from the Bilboes oxide mine. Motapa Exploration After the encouraging results from the 2024 exploration programme, a $2.8 million exploration programme is underway at Motapa for 2025, targeting sulphide and oxide resources across the Motapa property. With Motapa's location adjacent to Bilboes, significant synergies could be obtained should a viable resource be identified through the planned exploration programme. To the end of June 2025, a total of 1,788 meters of diamond drilling and 9,638 meters of reverse circulation drilling has been completed. A full overview of activities and results are expected to be provided during the second half of 2025. LEADERSHIP CHANGES Mr. Johan Holtzhausen retired from the Board and as chair of the Audit Committee in May 2025. Ms. Tariro Gadzikwa was appointed as chair of the Audit Committee. REPORTING CHANGES Caledonia will no longer publish financial statements and management’s discussion and analysis (MD&A) reports on a quarterly basis in accordance with Canadian securities regulations. This decision aligns with applicable exemptions under Canadian securities regulations, including National Instrument 71-102 – Continuous Disclosure and Other Exemptions Relating to Foreign Issuers, and reflects our status as an SEC foreign issuer with equivalent disclosure obligations outside Canada. We remain fully committed to transparent and timely disclosure of material information through the publication of our annual and half-yearly financial statements and via recognised regulatory channels, and, going forwards, we anticipate publishing revenue, costs and production results for the quarters for which we do not release detailed financial results (namely, the first and third quarters). This change does not affect our obligation to disclose any significant developments or risks that may materially impact the group’s financial position or performance. We will continue to provide comprehensive MD&A commentary as part of our annual and semiannual reporting cycle. OUTLOOK AND GUIDANCE Blanket is on track to achieve production within its updated guidance range of 75,500 to 79,500 ounces1 for 2025, while continuing to modernise operations and improve mining and operational cost efficiencies. Further exploration is being undertaken at Blanket, aiming to upgrade existing inferred mineral resources to measured and indicated categories, with the goal of extending the mine’s life. In addition, exploration is ongoing in target areas outside the current mine footprint within the Blanket mining lease area. Work continues on the feasibility study for the Bilboes sulphide project, including the assessment of new factors that may enhance the project’s economics. At Motapa, exploration efforts are progressing through a $2.8 million programme focused on both oxide and sulphide resources. INVESTOR CONFERENCE CALL Details of Investor and Analyst Presentation Conference Call Details A presentation for investors and analysts will be held as follows: When: August 13, 2025 at 2:00pm London time Topic: Q2 2025 Results Call for Investors Register in advance for this webinar: https://brrmedia.news/CMCL_Q225 ________________________ 1 Refer to the technical report entitled "NI 43-101 Technical Report on the Blanket Gold Mine, Zimbabwe" with effective date December 31, 2023 prepared by Caledonia Mining Corporation Plc and filed by the Company on SEDAR+ (https://www.sedarplus.ca) on May 15, 2024. Craig James Harvey, MGSSA, MAIG, Caledonia Vice President, Technical Services, has reviewed and approved the scientific and technical information contained in this news release. Craig James Harvey is a "Qualified Person" as defined by each of (i) the Canadian Securities Administrators' National Instrument 43-101 - Standards of Disclosure for Mineral Projects and (ii) sub-part 1300 of Regulation S-K of the U.S. Securities Act. Enquiries: Caledonia Mining Corporation Plc Mark LearmonthTel: +44 1534 679 800Camilla HorsfallTel: +44 7817 841 793  Cavendish Capital Markets Limited (Nomad and Joint Broker) Adrian HaddenTel: +44 207 397 1965Pearl KellieTel: +44 131 220 9775  Panmure Liberum (Joint Broker) Scott MathiesonTel: +44 20 3100 2000  Camarco, Financial PR/ IR (UK) Gordon PooleTel: +44 20 3757 4980Elfie Kent Fergus Young   3PPB (Financial PR, North America) Patrick ChidleyTel: +1 917 991 7701Paul DurhamTel: +1 203 940 2538  Curate Public Relations (Zimbabwe) Debra TatendaTel: +263 77802131  IH Securities (Private) Limited (VFEX Sponsor - Zimbabwe) Lloyd MlotshwaTel: +263 (242) 745 119/33/39   This announcement contains inside information which is disclosed in accordance with the Market Abuse Regulation (EU) No. 596/2014 (“MAR”) as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and is disclosed in accordance with the Company's obligations under Article 17 of MAR. Cautionary Note Concerning Forward-Looking Information Information and statements contained in this news release that are not historical facts are "forward-looking information" within the meaning of applicable securities legislation that involve risks and uncertainties relating, but not limited to Caledonia's current expectations, intentions, plans, and beliefs. Forward-looking information can often be identified by forward-looking words such as "anticipate", "believe", "expect", "goal", "plan", "target", "intend", "estimate", "could", "should", "may" and "will" or the negative of these terms or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions or statements about future events or performance. Examples of forward-looking information in this news release include: production guidance, expected recovery rates, our plans and timing regarding further exploration and drilling and development, future costs, the development of Bilboes and Motapa, the amount and funding of capital costs and the publication of the Bilboes feasibility study. This forward-looking information is based, in part, on assumptions and factors that may change or prove to be incorrect, thus causing actual results, performance or achievements to be materially different from those expressed or implied by forward-looking information. Such factors and assumptions include, but are not limited to: failure to establish estimated resources and reserves, the grade and recovery of ore which is mined varying from estimates, success of future exploration and drilling programs, reliability of drilling, sampling and assay data, assumptions regarding the representativeness of mineralization being inaccurate, success of planned metallurgical test-work, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required governmental, environmental or other project approvals, inflation, changes in exchange rates, fluctuations in commodity prices, delays in the development of projects and other factors. Security holders, potential security holders and other prospective investors should be aware that these statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements. Such factors include, but are not limited to: risks relating to estimates of mineral reserves and mineral resources proving to be inaccurate, fluctuations in gold price, risks and hazards associated with the business of mineral exploration, development and mining, risks relating to the credit worthiness or financial condition of suppliers, refiners and other parties with whom the Company does business; inadequate insurance, or inability to obtain insurance, to cover these risks and hazards, employee relations; relationships with and claims by local communities and indigenous populations; political risk; risks related to natural disasters, terrorism, civil unrest, public health concerns (including health epidemics or outbreaks of communicable diseases such as the coronavirus (COVID-19)); availability and increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development, including the risks of obtaining or maintaining necessary licenses and permits, diminishing quantities or grades of mineral reserves as mining occurs; global financial condition, the actual results of current exploration activities, changes to conclusions of economic evaluations, and changes in project parameters to deal with unanticipated economic or other factors, risks of increased capital and operating costs, environmental, safety or regulatory risks, expropriation, the Company's title to properties including ownership thereof, increased competition in the mining industry for properties, equipment, qualified personnel and their costs, risks relating to the uncertainty of timing of events including targeted production rate increase and currency fluctuations, risks related to potentially being unable to remedy the deficiency in control over accounting for deferred tax liabilities and risks related to potentially being unable to prevent financial statements misstatements in the future. Security holders, potential security holders and other prospective investors are cautioned not to place undue reliance on forward-looking information. By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and various future events will not occur. Caledonia undertakes no obligation to update publicly or otherwise revise any forward-looking information whether as a result of new information, future events or other such factors which affect this information, except as required by law. This news release is not an offer of the shares of Caledonia for sale in the United States or elsewhere. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the shares of Caledonia, in any province, state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such province, state or jurisdiction. Consolidated statements of profit or loss and other comprehensive income(in thousands of United States Dollars, unless indicated otherwise)For the Six months ended June 30Six months endedJune 30Unaudited 2025 2024 2025 2024    Restated*  Restated* Revenue 65,309 50,107 121,487 88,635 Royalty (3,507)(2,475)(6,278)(4,409)Production costs (23,954)(20,460)(46,576)(39,420)Depreciation (4,042)(4,239)(7,901)(8,058)Gross profit 33,806 22,933 60,732 36,748 Net foreign exchange loss (1,026)(2,182)(2,278)(7,064)Administrative expenses (4,363)(3,664)(8,961)(6,275)Fair value loss on derivative financial instrument - (174)(1,592)(476)Equity-settled share-based expense (226)(305)(82)(506)Cash-settled share-based (expense) / credit (285)(4)(443)(57)Other expenses (1,103)(664)(1,946)(1,264)Other income 75 185 141 349 Profit on the sale of non-current assets held for sale 8,540 - 8,540 - Operating profit  35,418 16,125 54,111 21,455 Finance income 121 3 127 9 Finance cost (602)(797)(1,502)(1,529)Profit before tax 34,937 15,331 52,736 19,935 Tax expense (11,341)(5,151)(17,977)(7,681)Profit for the period 23,596 10,180 34,759 12,254       Other comprehensive income     Items that are or may be reclassified to profit or loss     Exchange differences on translation of foreign operations 239 178 446 34 Total comprehensive income for the period 23,835 10,358 35,205 12,288       Profit attributable to:     Owners of the Company 20,487 8,283 29,402 9,769 Non-controlling interests 3,109 1,897 5,357 2,485 Profit for the period 23,596 10,180 34,759 12,254       Total comprehensive income attributable to:     Owners of the Company 20,726 8,461 29,848 9,803 Non-controlling interests 3,109 1,897 5,357 2,485 Total comprehensive income for the period 23,835 10,358 35,205 12,288       Earnings per share     Basic earnings per share (cents) 105.7 41.6 150.3 48.9 Diluted earnings per share (cents) 105.7 41.6 150.3 48.9 Adjusted earnings per share     Basic earnings per share (cents) 113.9 44.6 172.4 54.2 Dividends per share (cents) 14.0 14.0 28.0 28.0  * Refer to note 27. Summarised Consolidated Statements of Financial Position (in thousands of United States Dollars, unless indicated otherwise)UnauditedJun 30 Dec 31 Dec 31  As at2025 2024 2023      *Restated Total non-current assets300,646 287,046 274,074 Income tax receivable106 355 1,120 Inventories29,528 23,768 20,304 Derivative financial assets- - 88 Trade and other receivables9,364 12,675 9,952 Prepayments11,663 6,748 2,538 Fixed term deposit18,000 - - Cash and cash equivalents19,860 4,260 6,708 Assets held for sale- 13,512 13,519 Total assets389,167 348,364 328,303        Total non-current liabilities73,741 68,505 63,970 Cash-settled share-based payment751 634 920 Income tax payable9,122 2,958 10 Lease liabilities278 95 167 Loans and borrowings1,741 1,174 - Loan note instruments1,093 855 665 Trade and other payables29,137 26,647 20,503 Overdrafts11,649 12,928 17,740 Liabilities associated with assets held for sale- 104 128 Total liabilities127,512 113,900 104,103 Total equity261,655 234,464 224,200 Total equity and liabilities389,167 348,364 328,303         Consolidated statements of cash flows(in thousands of United States Dollars, unless indicated otherwise)Unaudited Three months ended June 30,Six months ended June 30,  2025 2024 2025 2024       Cash inflow from operations 34,111 20,988 52,668 27,523 Interest received 11 3 17 9 Finance costs paid (623)(710)(1,166)(1,283)Tax paid (5,415)(1,195)(10,246)(2,276)Net cash inflow from operating activities 28,084 19,086 41,273 23,973       Cash flows used in investing activities     Acquisition of property, plant and equipment (10,511)(6,897)(17,761)(10,638)Expenditure on exploration and evaluation assets (1,831)(733)(3,060)(1,163)Proceeds from sale of non-current asset held for sale (net of selling costs) 21,966 - 21,966 - Proceeds from the sale of property plant and equipment 17 - 17 - Acquisition of put options - (168)(1,592)(408)Investment in fixed term deposits (18,000)- (18,000)- Net cash used in investing activities (8,359)(7,798)(18,430)(12,209)      Cash flows from financing activities     Dividends paid (7,606)(2,912)(8,993)(5,632)Payment of lease liabilities (104)(38)(133)(75)Proceeds from loans and borrowings 1,259 2,032 1,259 2,032 Repayments of loans and borrowings (472)- (472)- Bonds - solar bond issue receipts (net of transaction cost) - 1,939 2,387 1,939 Net cash (used in) / from financing activities (6,923)1,021 (5,952)(1,736)      Net increase in cash and cash equivalents 12,802 12,309 16,891 10,028 Effect of exchange rate fluctuations on cash and cash equivalents (19)485 (12)(362)Net cash and cash equivalents at the beginning of the period (4,572)(14,160)(8,668)(11,032)Net cash and cash equivalents at the end of the period 8,211 (1,366)8,211 (1,366)